Compare IDEXX Laboratories, Inc. (IDXX) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs ProShares Ultra Semiconductors — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while ProShares Ultra Semiconductors trades at $94.84 (market cap $2.94B). The key difference: IDEXX Laboratories, Inc. is far larger — about 13.8× ProShares Ultra Semiconductors's market cap, and ProShares Ultra Semiconductors is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and ProShares Ultra Semiconductors for 29 Days on average.
| IDXX | USD | |
|---|---|---|
Market Cap | $40.43B | $2.94B |
Volume | 692,164 | 630,148 |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $113.53 |
52-Week Low | $504.70 | $43.19 |
Typical Hold Time | 46 Days | 29 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
USD stock is trading at $94.84, down 7.72% over the past 24 hours, with technical indicators showing a bullish overall signal despite the recent decline. The stock maintains strong moving average support with 9 buy signals versus 4 sell signals, while oscillators remain neutral. Recent corporate actions include a scheduled dividend payment of $0.13 per share for September 2026. Support levels are established at $93, $91, and $87, with resistance at $97, $100, and $104.
The stock's technical strength suggests potential recovery from current levels, though fundamental data remains limited. The bullish moving average configuration and upcoming dividend provide near-term catalysts, while the neutral RSI indicates room for movement. Key risks include market volatility and the need for clearer fundamental metrics to support current valuation levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
